e-learning
resources
Paris 2018
Sunday, 16.09.2018
Organoids and pluripotent stem cells
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Optimizing experimental research in respiratory diseases: an ERS Statement
M. Kolb (Hamilton (ON), Canada)
Source:
International Congress 2018 – Organoids and pluripotent stem cells
Session:
Organoids and pluripotent stem cells
Session type:
Symposium
Number:
279
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Kolb (Hamilton (ON), Canada). Optimizing experimental research in respiratory diseases: an ERS Statement. International Congress 2018 – Organoids and pluripotent stem cells
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Definition and history of sarcoidosis
Related content which might interest you:
Optimising experimental research in respiratory diseases: an ERS statement
Source: Eur Respir J, 51 (5) 1702133; 10.1183/13993003.02133-2017
Year: 2018
Optimising experimental research in respiratory diseases: an ERS statement
Source: Guideline 2018
Year: 2018
ERS statement on paediatric long-term noninvasive respiratory support
Source: Guideline 2022
Year: 2021
ATS/ERS Statement on occupational burden of respiratory disease
Source: International Congress 2019 – Occupational and epidemiology Grand Round
Year: 2019
ERS Statement: Exercise testing in the evaluation of interventional efficacy
Source: International Congress 2015 – Clinical relevance of exercise stress testing of the right ventricle pulmonary circulation unit
Year: 2015
ERS Statement on standardisation of cardiopulmonary exercise testing (CPET) in chronic lung diseases
Source: International Congress 2019 – Clinical Year in review
Year: 2019
ERS Statement: Smoking cessation in COPD and other pulmonary disorders
Source: International Congress 2015 – New advances in smoking cessation interventions
Year: 2015
ERS Statement: Diagnosis and treatment of primary spontaneous pneumothorax
Source: International Congress 2015 – ERS Task Forces and Guidelines: procedures, methodology and publication
Year: 2015
ERS/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases
Source: Eur Respir J, 55 (2) 1901208; 10.1183/13993003.01208-2019
Year: 2020
ERS Statement on Interventional bronchoscopy in children
Source: International Congress 2017 – Paediatric year in review: update on paediatric pulmonology
Year: 2017
Tele-monitoring of ventilator-dependent patients: a European Respiratory Society Statement
Source: Eur Respir J 2016; 48: 648-663
Year: 2016
Tele-monitoring of ventilator-dependent patients: a European Respiratory Society Statement
Source: Guideline 2017
Year: 2017
Genetic associations is part of the personalised answer: Report of ERS Statement on AATD
Source: International Congress 2017 – Personalised care for emphysema in COPD
Year: 2017
ERS Statement: Idiopathic pulmonary fibrosis
Source: International Congress 2015 – ERS Task Forces and Guidelines: procedures, methodology and publication
Year: 2015
ERS Statement on respiratory mechanics and muscle testing at rest and during exercise in chronic lung disorders
Source: International Congress 2019 – Clinical Year in review
Year: 2019
ERS Statement on Protracted Bacterial Bronchitis
Source: International Congress 2017 – Non-CF bronchiectasis in children
Year: 2017
ERS/TSANZ Statement on the management of reproduction and pregnancy in women with airways diseases
Source: Guideline 2020
Year: 2020
ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update
Source: Eur Respir J, 51 (5) 1702678; 10.1183/13993003.02678-2017
Year: 2018
ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update
Source: Guideline 2018
Year: 2018
ERS/EAN/ESO/ESRS Statement on the impact of sleep disorders on risk and outcome of stroke
Source: International Congress 2019 – State of the art session: Sleep and breathing disorders
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept